
DiaSorin Investor Relations Material
Latest events

Q1 2025
DiaSorin
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DiaSorin S.p.A.
Access all reports
Segment Data
Access more data
Revenue by
Geography
North America
Italy
Europe
RoW
Expenses by
Financials
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostic and molecular diagnostics testing kits. It offers reagents, analyzers, calibrators, test strips, and automated instruments; reagent kits for autoimmune diseases for laboratory in-vitro diagnostic use; reagents for the diagnosis of syphilis and HIV infections; kits for determining the level of hepatitis B, C, D, and E viruses; and enzymatic tests for assessment of liver function. The company also provides penicillins autoantibodies tests ; HLA autoantibodies tests; anti-ds-DNA autoantibodies; anti-COMP autoantibodiestests; thyroid autoantibodies tests; tumor markers tests; hematology tests; diabetes assays ; monoclonal antibodies ; and specialty diagnostics for rare disorders.
Key slides for DiaSorin S.p.A.


Q4 2024
DiaSorin S.p.A.


Q1 2025
DiaSorin S.p.A.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
DIA
Country
🇮🇹 Italy